{"id":9626,"date":"2026-07-20T17:08:03","date_gmt":"2026-07-20T09:08:03","guid":{"rendered":"https:\/\/www.zleygroup.com\/?p=9626"},"modified":"2026-07-20T17:23:46","modified_gmt":"2026-07-20T09:23:46","slug":"ascorbyl-tetraisopalmitate-formulation-guide","status":"publish","type":"post","link":"https:\/\/www.zleygroup.com\/es\/ascorbyl-tetraisopalmitate-formulation-guide\/","title":{"rendered":"Gu\u00eda de formulaci\u00f3n del tetraisopalmitato de ascorbilo para compradores"},"content":{"rendered":"<style id=\"zley-image-fix-9626\">#post-9626 .zley-post-featured{display:none!important}@media (max-width:767px){body.postid-9626 .mystickyelements-fixed{display:none!important}#post-9626 .zley-post-layout{grid-template-columns:minmax(0,1fr)!important}#post-9626 .zley-post-content{min-width:0!important;width:100%!important;max-width:100%!important}#post-9626 .wp-block-table{display:block;max-width:100%;overflow-x:auto;-webkit-overflow-scrolling:touch}#post-9626 figure.wp-block-image{width:100%!important;max-width:100%!important}#post-9626 .zley-post-content p,#post-9626 .zley-post-content h2,#post-9626 .zley-post-content h3{overflow-wrap:anywhere}}<\/style>\n<p>Ascorbyl Tetraisopalmitate is an oil-soluble vitamin C derivative used in brightening, antioxidant and skin-conditioning concepts. For a cosmetic buyer, however, the important questions are not limited to whether the ingredient can appear in a vitamin C serum. The grade must be identified correctly, incorporated into the right phase, protected through processing and packaging, and supported by a stability and safety program that matches the finished product.<\/p>\n<p>This guide is written for procurement teams, formulators, skincare brands and contract manufacturers evaluating <a href=\"https:\/\/www.zleygroup.com\/products\/ascorbyl-tetraisopalmitate\/\">ZLEY Ascorbyl Tetraisopalmitate<\/a> or an equivalent supplier grade. It separates published evidence from formula-specific proof and provides a practical qualification workflow from sample review to commercial release.<\/p>\n<div style=\"border-left:4px solid #18794e;background:#f4f8f6;padding:18px 20px;margin:24px 0;\">\n<p><strong>Respuesta r\u00e1pida:<\/strong> Ascorbyl Tetraisopalmitate is a lipophilic tetraester of ascorbic acid supplied as a colorless to pale-yellow liquid. It belongs in the oil phase rather than the water phase. ZLEY recommends 0.5-4.0% as a formulation screening range, but the commercial level should be chosen from assay recovery, color, odor, packaging, tolerance and claim-support results in the complete formula. It is not the same INCI as Tetrahexyldecyl Ascorbate.<\/p>\n<\/div>\n<figure class=\"wp-block-image\" style=\"max-width:760px;margin:28px auto;\"><a href=\"https:\/\/www.zleygroup.com\/products\/ascorbyl-tetraisopalmitate\/\" style=\"display:block;aspect-ratio:20\/17;overflow:hidden;background:#f3f4f4;\"><img fetchpriority=\"high\" decoding=\"async\" src=\"https:\/\/www.zleygroup.com\/wp-content\/uploads\/2025\/06\/c800453d03b3deeaeb7f9e4457857e49.jpg\" alt=\"Ascorbyl Tetraisopalmitate oil-soluble vitamin C derivative for skincare formulation\" width=\"800\" height=\"800\" style=\"display:block;width:100%;height:100%;object-fit:cover;object-position:center top;\" title=\"\"><\/a><figcaption>Ascorbyl Tetraisopalmitate is supplied as a colorless to pale-yellow oil-soluble liquid. Confirm the exact grade, assay method and storage controls before scale-up.<\/figcaption><\/figure>\n<h2>\u00bfQu\u00e9 es el tetraisopalmitato de ascorbilo?<\/h2>\n<p>The Cosmetic Ingredient Review describes Ascorbyl Tetraisopalmitate as the tetraester of ascorbic acid and isopalmitic acid. The esterified structure is lipophilic, which changes where the material is incorporated and how it behaves compared with free L-ascorbic acid. The ingredient is used as an antioxidant, emollient and skin-conditioning agent in cosmetic formulations.<\/p>\n<figure class=\"wp-block-table\">\n<table>\n<thead>\n<tr>\n<th>Qualification item<\/th>\n<th>Referencia del comprador<\/th>\n<th>What to verify on the supplier document<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Denominaci\u00f3n INCI<\/td>\n<td>Tetraisopalmitato de ascorbilo<\/td>\n<td>The INCI must appear consistently on the TDS, SDS, COA and commercial invoice.<\/td>\n<\/tr>\n<tr>\n<td>Definition<\/td>\n<td>Tetraester of ascorbic acid and isopalmitic acid<\/td>\n<td>Confirm grade composition and whether any carrier, antioxidant or processing aid is present.<\/td>\n<\/tr>\n<tr>\n<td>CAS references<\/td>\n<td>161436-56-2 and 183476-82-6 are listed in the CIR assessment<\/td>\n<td>Ask the supplier which identifier applies to the supplied grade and why.<\/td>\n<\/tr>\n<tr>\n<td>Physical form<\/td>\n<td>Liquid; colorless to light yellow<\/td>\n<td>Set an incoming color limit rather than accepting an unrestricted visual description.<\/td>\n<\/tr>\n<tr>\n<td>Density<\/td>\n<td>About 0.94 g\/mL at 20&deg;C in the CIR data table<\/td>\n<td>Use the grade-specific specification for receiving inspection.<\/td>\n<\/tr>\n<tr>\n<td>Water solubility<\/td>\n<td>Less than 0.09 mg\/L at 95&deg;C and approximately pH 7.5 in the CIR data table<\/td>\n<td>Treat the material as oil soluble; do not plan direct dissolution in the water phase.<\/td>\n<\/tr>\n<tr>\n<td>ZLEY screening range<\/td>\n<td>0.5-4.0%<\/td>\n<td>This is a development range, not a universal efficacy or regulatory guarantee.<\/td>\n<\/tr>\n<\/tbody>\n<\/table><figcaption>Identity and physical-property references are summarized from the <a href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/10915818221093545\" target=\"_blank\" rel=\"noopener nofollow\">CIR safety assessment<\/a> and must be reconciled with the current supplier specification.<\/figcaption><\/figure>\n<h3>Do not substitute Tetrahexyldecyl Ascorbate by name<\/h3>\n<p>Ascorbyl Tetraisopalmitate and Tetrahexyldecyl Ascorbate are often discussed together because both are lipophilic vitamin C derivatives. They are nevertheless separate INCI entries in the CIR assessment and have different definitions and CAS references. A buyer should not approve a substitution because two marketing names sound similar or because both materials are clear oily liquids. Formula behavior, assay method, impurity profile, regulatory documentation and label declaration must be reviewed for the exact material.<\/p>\n<p>When comparing supplier offers, put the INCI, CAS reference, active composition and analytical method on the same comparison sheet. This prevents a lower-priced but chemically different grade from entering a validated formula.<\/p>\n<h2>What Does the Published Evidence Actually Show?<\/h2>\n<p>Published studies provide useful development hypotheses, but they do not transfer automatically to a new formula. Vehicle, concentration, packaging, application frequency, test population and endpoint all affect the result. The evidence below should guide prototype design and claim planning, not replace finished-product testing.<\/p>\n<figure class=\"wp-block-table\">\n<table>\n<thead>\n<tr>\n<th>Pruebas<\/th>\n<th>Study conditions<\/th>\n<th>Practical interpretation<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16935471\/\" target=\"_blank\" rel=\"noopener nofollow\">2006 pigmentation study<\/a><\/td>\n<td>Twenty-two subjects; 3% cream applied after simulated UV exposure; pigmentation followed for up to three weeks.<\/td>\n<td>The published formula supported a pigmentation-related effect under controlled conditions. It does not prove that every 3% commercial serum will perform identically.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22974986\/\" target=\"_blank\" rel=\"noopener nofollow\">2012 stability and in vivo study<\/a><\/td>\n<td>A formulation with 1% tetra-isopalmitoyl ascorbic acid was evaluated by HPLC under heat stress for 35 days and in preclinical and clinical skin measurements.<\/td>\n<td>The authors reported medium chemical stability and improvements in hydration and microrelief. The paper reinforces the need to measure assay, not assume derivative stability.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34910367\/\" target=\"_blank\" rel=\"noopener nofollow\">Randomized split-face trial<\/a><\/td>\n<td>Three groups of 23 women used 1%, 2% or 3% VC-IP cream versus placebo twice daily for eight weeks on the periorbital area.<\/td>\n<td>The tested creams improved wrinkle-related measurements. Claims for a new product still require a matched protocol and statistically defensible endpoint.<\/td>\n<\/tr>\n<tr>\n<td><a href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/10915818221093545\" target=\"_blank\" rel=\"noopener nofollow\">CIR safety review<\/a><\/td>\n<td>Weight-of-evidence review of cosmetic use, toxicology, irritation and sensitization information.<\/td>\n<td>The panel concluded the reviewed ascorbic acid esters and ether were safe in the practices of use and concentration described. Finished-product safety assessment remains necessary.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n<p>A separate open-access study on combinations of vitamin A, C and E derivatives also illustrates that antioxidant systems must be evaluated as complete formulas, not as isolated ingredient stories. The paper is useful background for designing stability work, but it should not be used to claim synergy without testing the intended combination. See the <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6268122\/\" target=\"_blank\" rel=\"noopener nofollow\">full stability study in PubMed Central<\/a>.<\/p>\n<h2>How to Formulate With Ascorbyl Tetraisopalmitate<\/h2>\n<h3>1. Put the material in the oil system<\/h3>\n<p>Ascorbyl Tetraisopalmitate is not a water-soluble replacement for L-ascorbic acid. For emulsions, pre-disperse or dissolve it in a compatible emollient portion and verify clarity before emulsification or cool-down addition. For anhydrous serums, evaluate miscibility in the complete oil blend rather than in a single carrier. Cloudiness, separation or crystallization after 24 hours and after temperature cycling can expose a poor carrier choice early.<\/p>\n<p>Do not force the material into water with excessive surfactant only to make a clear bench sample. That approach can change mildness, sensory profile and preservative behavior. If a clear aqueous-format product is required, a different vitamin C derivative such as <a href=\"https:\/\/www.zleygroup.com\/products\/3-o-ethyl-ascorbic-acid\/\">\u00c1cido 3-O-etil asc\u00f3rbico<\/a> may be a more logical starting point, subject to its own pH and stability work.<\/p>\n<h3>2. Screen use level rather than selecting it from marketing<\/h3>\n<p>ZLEY lists 0.5-4.0% as a recommended range. A useful first design of experiments can compare 0.5%, 1%, 2%, 3% and 4% against a vehicle control. At each level, record raw-material assay contribution, color, odor, viscosity, emulsion droplet behavior, skin feel and recoverable active after processing. The highest concentration is not automatically the best commercial formula.<\/p>\n<p>Set the final level from the lowest concentration that meets the product brief and claim protocol while remaining stable in the intended package. Cost-in-use should be calculated from active assay and validated yield, not only from price per kilogram.<\/p>\n<h3>3. Control heat, air, light and trace metals<\/h3>\n<p>Esterification can improve handling relative to free ascorbic acid, but it does not make a finished formula immune to oxidation. Unless the grade-specific TDS supports a particular hot-process route, compare late oil-phase or cool-down addition with the standard process. Record bulk temperature and exposure time, then measure assay after manufacture. A fixed universal addition temperature should not be copied between suppliers without evidence.<\/p>\n<p>Use low-peroxide oils, clean processing equipment and a package that limits repeated air and light exposure. An opaque or UV-limiting airless package is often a better screening candidate than a clear dropper. A chelator in the water phase and a compatible oil-phase antioxidant can be evaluated, but neither should be treated as a substitute for assay and package testing.<\/p>\n<h3>4. Do not copy the low-pH rules of L-ascorbic acid<\/h3>\n<p>The ingredient resides mainly in the oil phase, so the formula does not need to mimic the highly acidic pH strategy used for free L-ascorbic acid. The aqueous-phase pH still matters for emulsifier performance, preservation, other actives and skin tolerance. Choose pH for the complete system, then confirm active recovery and color stability at the intended range.<\/p>\n<h2>Prototype Development Map<\/h2>\n<figure class=\"wp-block-table\">\n<table>\n<thead>\n<tr>\n<th>Format<\/th>\n<th>First development question<\/th>\n<th>Critical failure modes<\/th>\n<th>Useful checks<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Anhydrous face oil<\/td>\n<td>Is the ingredient miscible in the full oil blend at use and storage temperatures?<\/td>\n<td>Haze, sediment, odor drift, oxidation and package interaction<\/td>\n<td>Clarity, peroxide value of carriers, active assay, color and light\/package comparison<\/td>\n<\/tr>\n<tr>\n<td>Oil-in-water serum or cream<\/td>\n<td>Which oil-phase carrier and addition route give reproducible recovery?<\/td>\n<td>Oil separation, viscosity loss, color shift and assay loss<\/td>\n<td>Centrifuge, microscopy, pH, viscosity, droplet size and HPLC assay<\/td>\n<\/tr>\n<tr>\n<td>Water-in-oil cream<\/td>\n<td>Does the active alter internal-phase stability or sensory drag?<\/td>\n<td>Phase inversion, graininess and uneven active distribution<\/td>\n<td>Microscopy, freeze-thaw, assay uniformity and application testing<\/td>\n<\/tr>\n<tr>\n<td>Multi-active treatment<\/td>\n<td>Can all actives share the same package, pH and oxidation-control strategy?<\/td>\n<td>Color formation, odor, irritation and incompatible claim conditions<\/td>\n<td>Factorial stability study, tolerance screen and packaged-product assay<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n<h2>Compatibility With Common Skincare Actives<\/h2>\n<h3>Niacinamida<\/h3>\n<p>Niacinamide is normally handled in the water phase while Ascorbyl Tetraisopalmitate is handled in the oil phase. The pair can be evaluated in one emulsion, but compatibility should be established through pH, color, odor, assay and tolerance data. Do not rely on the broad internet claim that all vitamin C and niacinamide combinations are either always incompatible or always synergistic.<\/p>\n<h3>Retinoids<\/h3>\n<p>Oil compatibility can make retinoid combinations technically possible, but a shared oil phase also concentrates the stability burden. Light, oxygen, package headspace and irritation potential need a combined test plan. If using Hydroxypinacolone Retinoate, qualify its carrier and assay separately rather than treating the premix concentration as pure active.<\/p>\n<h3>Tocopherol and ferulate systems<\/h3>\n<p>Tocopherol, <a href=\"https:\/\/www.zleygroup.com\/products\/ethyl-ferulate\/\">Ferulato de etilo<\/a> y <a href=\"https:\/\/www.zleygroup.com\/products\/zleyaf-l-arginine-ferulate\/\">L-Arginine Ferulate<\/a> may support different antioxidant or positioning strategies. They are not interchangeable: solubility, phase location and supplier grade differ. Any claim of improved stability or biological synergy must be demonstrated in the intended formulation.<\/p>\n<h2>Build a Stability Program Around Assay Recovery<\/h2>\n<p>A visually acceptable formula can still lose active. Conversely, a small color change may not mean the assay has failed. The stability specification should combine chemical, physical, microbiological and package measurements.<\/p>\n<figure class=\"wp-block-table\">\n<table>\n<thead>\n<tr>\n<th>Study<\/th>\n<th>Recommended observations<\/th>\n<th>Decision use<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Initial process recovery<\/td>\n<td>Active assay in raw material, bulk after manufacture and filled package<\/td>\n<td>Separates raw-material variability from process loss.<\/td>\n<\/tr>\n<tr>\n<td>Accelerated temperature<\/td>\n<td>Assay, color, odor, pH, viscosity, phase behavior and package interaction<\/td>\n<td>Compares formula and package candidates; it does not by itself assign shelf life.<\/td>\n<\/tr>\n<tr>\n<td>Freeze-thaw and cycling<\/td>\n<td>Separation, graininess, haze, crystallization and redispersion<\/td>\n<td>Challenges physical robustness during transport and seasonal exposure.<\/td>\n<\/tr>\n<tr>\n<td>Light exposure<\/td>\n<td>Protected control versus intended package; assay and color<\/td>\n<td>Determines whether clear, tinted or opaque packaging is justified.<\/td>\n<\/tr>\n<tr>\n<td>Air exposure<\/td>\n<td>Airless pump versus dropper or jar; headspace and repeated-opening simulation<\/td>\n<td>Quantifies the package contribution to oxidation control.<\/td>\n<\/tr>\n<tr>\n<td>Real-time stability<\/td>\n<td>All release specifications plus microbiology and package functionality<\/td>\n<td>Supports the commercial shelf-life decision.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n<p>Use a stability-indicating analytical method capable of separating the target ingredient from relevant degradation products or interferences. Ask whether the supplier&#8217;s assay method is suitable for the raw material only or can be transferred to the finished matrix. Acceptance limits should be defined from the formula, claim and regulatory strategy rather than borrowed from another brand.<\/p>\n<h2>Supplier Qualification and Incoming QC<\/h2>\n<h3>Documents to reconcile before approval<\/h3>\n<ul>\n<li>TDS, SDS and a current lot-specific COA<\/li>\n<li>INCI, applicable CAS reference and full composition disclosure<\/li>\n<li>Assay method, chromatographic conditions and reference-standard information<\/li>\n<li>Appearance and color limits, density, refractive index, acid value and other grade-relevant controls<\/li>\n<li>Peroxide or oxidation-related controls where applicable<\/li>\n<li>Residual solvents, heavy metals, microbiological limits and allergen\/GMO statements as required by the target market<\/li>\n<li>Shelf life, retest policy, storage temperature and light\/air protection<\/li>\n<li>Manufacturing site, change-control policy and traceability statement<\/li>\n<li>Country-specific cosmetic regulatory support and claim limitations<\/li>\n<\/ul>\n<p>Do not accept a generic vitamin C derivative COA. The specification must identify Ascorbyl Tetraisopalmitate and the supplied grade. If the product contains a carrier or antioxidant, the assay and recommended use level must be interpreted on an as-supplied basis.<\/p>\n<h3>Incoming tests that catch common failures<\/h3>\n<p>At minimum, compare identity, appearance\/color, odor, density and assay with the approved reference lot. Depending on risk and annual volume, add acid value, peroxide value, residual solvent or chromatographic impurity review. Retain a sealed sample from each lot under controlled conditions so that later color, odor or assay complaints can be investigated against the received material.<\/p>\n<h2>Safety, Regulation and Claims<\/h2>\n<p>El <a href=\"https:\/\/journals.sagepub.com\/doi\/full\/10.1177\/10915818221093545\" target=\"_blank\" rel=\"noopener nofollow\">CIR Expert Panel safety assessment<\/a> concluded that the reviewed ascorbic acid ethers and esters, including Ascorbyl Tetraisopalmitate, were safe in the practices of use and concentration described. The same assessment reports that an undiluted trade material produced sensitization in a guinea-pig maximization test, while a human repeat-insult patch test of a 10% dilution in silicone involving 102 subjects was non-irritating and non-sensitizing. Published case reports also mean that individual reactions cannot be treated as impossible.<\/p>\n<p>These findings support a risk-based approach: verify raw-material purity, assess the complete formula, establish consumer warnings where appropriate and obtain a qualified safety assessment for the target market. A supplier conclusion is not a substitute for finished-product tolerance work.<\/p>\n<p>For EU projects, use the <a href=\"https:\/\/single-market-economy.ec.europa.eu\/sectors\/cosmetics\/cosmetic-ingredient-database_en\" target=\"_blank\" rel=\"noopener nofollow\">Base de datos CosIng de la Comisi\u00f3n Europea<\/a> as an information source, not as proof that a particular product or claim is approved. CosIng itself notes that an ingredient listing does not mean it is authorized for every use. Check the current Cosmetics Regulation annexes, national requirements and responsible-person assessment at launch.<\/p>\n<p>Keep claims cosmetic and evidence-matched. &#8220;Helps improve the appearance of uneven tone&#8221; or &#8220;supports antioxidant skincare&#8221; may be testable cosmetic directions. Claims to treat melasma, cure hyperpigmentation or prevent disease can move the product into a different regulatory category. The exact wording must follow the target market and the study design used on the finished product.<\/p>\n<h2>RFQ Information That Produces Comparable Quotations<\/h2>\n<p>A useful RFQ lets suppliers quote the same technical scope. Include the following fields so that price comparisons do not hide grade differences:<\/p>\n<figure class=\"wp-block-table\">\n<table>\n<thead>\n<tr>\n<th>RFQ field<\/th>\n<th>Por qu\u00e9 es importante<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Exact INCI and acceptable CAS reference<\/td>\n<td>Prevents substitution with Tetrahexyldecyl Ascorbate or another vitamin C ester.<\/td>\n<\/tr>\n<tr>\n<td>Required assay and composition<\/td>\n<td>Allows cost-in-use comparison on an active basis.<\/td>\n<\/tr>\n<tr>\n<td>Target application and planned use level<\/td>\n<td>Lets the supplier flag solubility, processing or package risks.<\/td>\n<\/tr>\n<tr>\n<td>Target countries<\/td>\n<td>Defines the regulatory and documentation package.<\/td>\n<\/tr>\n<tr>\n<td>Annual volume and pilot quantity<\/td>\n<td>Separates sample, pilot and commercial lead times.<\/td>\n<\/tr>\n<tr>\n<td>Required tests and change-control notice<\/td>\n<td>Aligns incoming QC and future requalification expectations.<\/td>\n<\/tr>\n<tr>\n<td>Packaging, storage and transport conditions<\/td>\n<td>Reduces preventable oxidation or temperature excursions.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/figure>\n<h2>Preguntas frecuentes<\/h2>\n<h3>Is Ascorbyl Tetraisopalmitate water soluble?<\/h3>\n<p>No. It is a lipophilic material with very low reported water solubility. Plan oil-phase incorporation and verify miscibility in the actual carrier blend.<\/p>\n<h3>\u00bfCon qu\u00e9 nivel de uso deber\u00eda empezar un formulador?<\/h3>\n<p>ZLEY recommends screening 0.5-4.0%. A structured ladder such as 0.5%, 1%, 2%, 3% and 4% is more informative than choosing one level. Select the commercial concentration from assay, stability, tolerance, sensory and claim results.<\/p>\n<h3>Is it the same as Tetrahexyldecyl Ascorbate?<\/h3>\n<p>No. The CIR assessment lists them as separate ingredients with different definitions and CAS references. Confirm the exact INCI and composition before approving any substitution.<\/p>\n<h3>Can it be used with niacinamide?<\/h3>\n<p>It can be evaluated in the same emulsion because the ingredients normally occupy different phases. The finished formula still needs pH, color, assay, preservation and tolerance testing.<\/p>\n<h3>Does oil solubility guarantee better skin penetration?<\/h3>\n<p>No single physical property guarantees clinical performance. Lipophilicity affects partitioning and vehicle design, but delivery depends on the complete formula, concentration, application and skin model. Avoid turning a structural feature into an untested efficacy claim.<\/p>\n<h3>Is an amber dropper sufficient packaging?<\/h3>\n<p>Not necessarily. Compare the intended dropper with an airless or lower-headspace package under light and repeated-opening conditions. The decision should be supported by active assay and color data.<\/p>\n<h2>Buyer Takeaway<\/h2>\n<p>Ascorbyl Tetraisopalmitate is most valuable when it is treated as a defined, assay-controlled oil-soluble active rather than a generic &#8220;stable vitamin C.&#8221; Confirm identity, distinguish it from Tetrahexyldecyl Ascorbate, incorporate it through a validated oil-phase process, and build stability around recoverable active in the final package. A defensible commercial formula connects supplier qualification, analytical recovery, safety assessment and claim evidence in one development plan.<\/p>","protected":false},"excerpt":{"rendered":"<p>A technical sourcing and formulation guide to Ascorbyl Tetraisopalmitate covering identity, oil solubility, evidence, use-level screening, stability, safety, quality control, claims and RFQ requirements.<\/p>","protected":false},"author":1,"featured_media":8131,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[69,70],"tags":[],"class_list":["post-9626","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-active-ingredients","category-cosmetic-formulation"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/posts\/9626","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/comments?post=9626"}],"version-history":[{"count":0,"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/posts\/9626\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/media\/8131"}],"wp:attachment":[{"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/media?parent=9626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/categories?post=9626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.zleygroup.com\/es\/wp-json\/wp\/v2\/tags?post=9626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}